Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by 40Baggson Jan 12, 2019 2:10pm
101 Views
Post# 29223274

RE:RE:RE:Altria deal comments!

RE:RE:RE:Altria deal comments!Its still playing a risky game if there was no solid plan in place following an offer dismissal from a whale like Altria. We wont be trading at the 15-20 range anytime soon so were unlikely to see a $20+ equity buy offer near-term. Hopefully Diageo, Pepsi, Coke or Bayer are in the mix now that Altria is tied with Cron. I agree that long-term, tobacco as an industry is the opposite of wellness and couldve been a mistake to be tied with, but there better be a superior plan in place for partnership. We have been far too sluggish as a “Big 3 LP” of an explosive industry in which we can command product pricing as the margins are squeezed, hopefully those shakles have been removed.


jayjay2020 wrote:
thorgb1 wrote:
castle123 wrote: I keep laughing at these posts that claim Vic blew the Altria deal! Were you at the table? NO.  You wanted a quick deal, move APH to $25 sell and run. 
I wonder what the same bloggers will be saying in 2-3 years when APHA is a global glomerate trading at $50-$60 a share.
i know what you will be saying! “ sure glad Vic didn’t sell out to Altria!”
Have a nice day!


Altria was a big, big mistake by Vic any way you slice it. It would be a much easier run for APHA to 50 bucks with a couple of billion $$ war chest in the bank and never having to worry about financing again. A big investment would have been good for short term gains, and provided long term stability. And, most don’t know, there was apparently another household name in the shadows ready to piggy back on the Altria deal and move in for a major JV that would have rocked the whole industry. That deal gets done, the shorts never show up and this is probably never under $20 again. Instead, lots of people lost a lot of money and had terrible holidays. It was a critical error.


I still feel any MJ company that ties themselves to a tobacco company just can ethically and conscientiously be in the pharma or wellness business. I think APHA partnering with Altria would have been a mistake for this reason.


Bullboard Posts